Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Digitalis Ventures
AddedFeb 15, 2024
UpdatedJun 28, 2026
Digitalis Ventures

Digitalis Ventures

Operating

Digitalis: A venture capital firm investing in innovative solutions for human and animal health.

Location
New York City, NY, US
Founded
2016
Firm
Compare
Portfolio
Employees
News
Website

Investments

Gallant
Gallant

Total Raised

$15M

Rounds

1

Series A$15MJanuary 2024
Native Pet
Native Pet

Total Raised

$17.9M

Rounds

4

Series B$11MAugust 2023
Series A$6MMarch 2022
EpiBiologics
EpiBiologics

Total Raised

$73M

Rounds

2

Series A$23MJuly 2023
Companion
Companion

Total Raised

$14M

Rounds

3

Series Unknown$6MApril 2023
Smalls
Smalls
Series B

Total Raised

$28M

Rounds

8

Series B$19MMarch 2023
Switch Therapeutics
Switch Therapeutics

Total Raised

$52M

Rounds

1

Series A$52MMarch 2023
Onc.AI
Onc.AI

Total Raised

$31M

Rounds

2

Series A$25MJanuary 2023
Bonum Therapeutics
Bonum Therapeutics

Total Raised

$93M

Rounds

1

Series A$93MNovember 2022
MySimplePetLab
MySimplePetLab

Total Raised

$9.7M

Rounds

3

Series A$5MNovember 2022
Elemental Machines
Elemental Machines

Total Raised

$59.9M

Rounds

10

Series B$41MNovember 2022
Matchpoint Therapeutics
Matchpoint Therapeutics

Total Raised

$100M

Rounds

2

Series A$70MOctober 2022
Scratch Financial
Scratch Financial

Total Raised

$68.1M

Rounds

7

Series C$35MSeptember 2022
Faeth Therapeutics
Faeth Therapeutics

Total Raised

$67M

Rounds

4

Series A$47MJune 2022
Seed$20MJanuary 2022
Nuvig Therapeutics
Nuvig Therapeutics

Total Raised

$47M

Rounds

1

Series A$47MMay 2022
Ness
Ness

Total Raised

$15.5M

Rounds

1

Seed$15.5MMay 2022
TellTail
TellTail

Total Raised

$3.4M

Rounds

1

Seed$3.4MApril 2022
Nacho Eats
Nacho Eats

Total Raised

$14M

Rounds

3

Series A$14MFebruary 2022
Terray Therapeutics
Terray Therapeutics

Total Raised

$80M

Rounds

5

Series A$60MFebruary 2022
Galatea Bio
Galatea Bio

Total Raised

$17M

Rounds

2

Seed$7MNovember 2021
GRO Biosciences
GRO Biosciences

Total Raised

$32.3M

Rounds

6

Series A$25MNovember 2021
Biomilq
Biomilq

Total Raised

$24.5M

Rounds

3

Series A$21MOctober 2021
Kingdom
Kingdom

Total Raised

$26.5M

Rounds

8

Series A$25MOctober 2021
UnifiHealth
UnifiHealth

Total Raised

$6.8M

Rounds

2

Seed$5.4MSeptember 2021